Monopar Therapeutics MNPR Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's shares (basic)?
- Monopar Therapeutics (MNPR) reported shares (basic) of 8.5M in Q1 2026.
- How has Monopar Therapeutics's shares (basic) changed year-over-year?
- Monopar Therapeutics's shares (basic) increased by 22.2% year-over-year, from 7M to 8.5M.
- What is the long-term trend for Monopar Therapeutics's shares (basic)?
- Over 2 years (2023 to 2025), Monopar Therapeutics's shares (basic) has grown at a -5.8% compound annual growth rate (CAGR), from 32.1M to 28.5M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.